Page 3 - Japanese (NIKKEI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Apr 23, 2024

Explore the Japanese (NIKKEI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

87 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

7707

Precision System Science
JP¥201.000%-43.2%JP¥5.6bn/aPS1.3xn/a0%

4596

Kubota Pharmaceutical Holdings
JP¥70.000%-36.4%JP¥3.9bn/aPS101xn/an/a

4548

Seikagaku
JP¥746.000%-9.4%JP¥40.7bJP¥800.00PE31.1xE14.7%3.5%

4978

ReproCELL
JP¥139.000%-39.6%JP¥12.3bn/aPS4.9xE57.4%n/a

2370

MEDINET
JP¥46.000%-32.4%JP¥11.8bn/an/an/an/a

4507

Shionogi
JP¥7,343.000%20.3%JP¥2.1tJP¥7,720.77PE13.5xE-0.6%2.0%

4883

Modalis Therapeutics
JP¥77.000%-72.3%JP¥2.6bn/aPB1.9xn/an/a

4564

OncoTherapy Science
JP¥19.000%-50.0%JP¥4.1bn/aPS4.6xn/an/a

2309

CMIC HOLDINGS
JP¥2,644.000%26.6%JP¥44.7bn/aPE8.4xn/a1.9%

4884

Kringle Pharma
JP¥583.00-0.2%-31.6%JP¥3.8bn/aPS54.2xn/an/a

4892

Cyfuse Biomedical K.K
JP¥701.00-0.1%-47.6%JP¥5.5bn/aPS90.7xn/an/a

4882

Perseus Proteomics
JP¥331.00-0.3%14.9%JP¥3.9bn/aPS40.8xn/an/a

6090

Human Metabolome Technologies
JP¥659.00-0.5%-5.9%JP¥3.9bn/aPE13.8xn/a2.3%

4598

Delta-Fly Pharma
JP¥809.00-0.4%-31.0%JP¥6.7bn/aPB3.9xn/an/a

4584

Kidswell Bio
JP¥141.00-0.7%-41.0%JP¥5.5bJP¥800.00n/aE90.3%n/a

4583

Chiome Bioscience
JP¥127.00-0.8%-35.9%JP¥7.0bn/aPS10.2xn/an/a

4571

NANO MRNALtd
JP¥178.00-0.6%-17.6%JP¥12.6bn/aPS76.4xn/an/a

4575

CanBas
JP¥456.00-0.9%-71.4%JP¥8.3bn/aPB2.6xn/an/a

8095

Astena Holdings
JP¥486.00-0.4%8.5%JP¥19.3bn/aPE11.9xn/a3.7%

4572

Carna Biosciences
JP¥452.00-1.1%-35.8%JP¥7.8bn/aPS4.8xn/an/a

4593

Healios K.K
JP¥152.00-0.7%-47.9%JP¥13.8bJP¥280.00PS113.2xE15.8%n/a

4576

D. Western Therapeutics Institute
JP¥104.00-3.7%-48.8%JP¥3.5bn/aPS7.8xn/an/a

7079

WDB coco
JP¥4,525.00-1.2%-4.2%JP¥11.0bJP¥9,000.00PE14.1xE10.8%n/a

130A

Veritas In Silico
JP¥1,652.00-2.4%n/aJP¥10.8bn/an/an/an/a
Page 3 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.